Abstract:Brain tumors are among the most lethal tumors. Glioblastoma, the most frequent primary brain tumor in adults, has a median survival time of approximately 15 months after diagnosis or a five-year survival rate of 10%; the recurrence rate is nearly 90%. Unfortunately, this prognosis has not improved for several decades. The lack of progress in the treatment of brain tumors has been attributed to their high rate of primary therapy resistance. Challenges such as pronounced inter-patient variability, intratumoral heterogeneity, and drug delivery across the blood–brain barrier hinder progress. A comprehensive, multiscale understanding of the disease, from the molecular to the whole tumor level, is needed to address the intratumor heterogeneity resulting from the coexistence of a diversity of neoplastic and non-neoplastic cell types in the tumor tissue. By contrast, inter-patient variability must be addressed by subtyping brain tumors to stratify patients and identify the best-matched drug(s) and therapies for a particular patient or cohort of patients. Accomplishing these diverse tasks will require a new framework, one involving a systems perspective in assessing the immense complexity of brain tumors. This would in turn entail a shift in how clinical medicine interfaces with the rapidly advancing high-throughput (HTP) technologies that have enabled the omics-scale profiling of molecular features of brain tumors from the single-cell to the tissue level. However, several gaps must be closed before such a framework can fulfill the promise of precision and personalized medicine for brain tumors. Ultimately, the goal is to integrate seamlessly multiscale systems analyses of patient tumors and clinical medicine. Accomplishing this goal would facilitate the rational design of therapeutic strategies matched to the characteristics of patients and their tumors. Here, we discuss some of the technologies, methodologies, and computational tools that will facilitate the realization of this vision to practice.

Complexity of Brain Tumors

Multiscale modeling of glioma pseudopalisades: contributions from the tumor microenvironment

Mathematical modeling of glioma invasion and therapy approaches via kinetic theory of active particles

Fractal Dimension and Universality in Avascular Tumor Growth

Universal scaling laws rule explosive growth inhuman cancers

Dynamics and Pattern Formation in Invasive Tumor Growth

Mathematical Modelling of Glioblastomas Invasion within the Brain: A 3D Multi-Scale Moving-Boundary Approach

Modelling and simulation of anisotropic growth in brain tumours through poroelasticity: A study of ventricular compression and therapeutic protocols

Fractal analysis of microvascular networks in malignant brain tumors

Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate

Morphogenesis of the tumor patterns

Modeling tumor growth: a simple individual-based model and its analysis

Mathematical model of brain tumour growth with drug resistance

Fractality in tumor growth at the avascular stage from a generalization of the logistic-Gompertz dynamics

A Systems Approach to Brain Tumor Treatment

Quantifying the Growth of Glioblastoma Tumors Using Multimodal MRI Brain Images

Complex Far-Field Geometries Determine the Stability of Solid Tumor Growth with Chemotaxis

Phase transition in tumor growth VIII: The spatiotemporal of avascular evolution

Neural parameters estimation for brain tumor growth modeling

Modeling glioma invasion with anisotropy- and hypoxia-triggered motility enhancement: From subcellular dynamics to macroscopic PDEs with multiple taxis

Mathematical Modelling of a Brain Tumour Initiation and Early Development: A Coupled Model of Glioblastoma Growth, Pre-Existing Vessel Co-Option, Angiogenesis and Blood Perfusion